|Dr. Robert E. W. Hancock FRSC, OC, Ph.D.||Exec. Chairman||120k||N/A||N/A|
|Mr. Joel Shacker||CEO & Director||120k||N/A||1991|
|Mr. Geoffrey Balderson||CFO, Sec. & Director||N/A||N/A||1978|
|Dr. Santiago Ferro||Chief Medical Officer||100k||N/A||N/A|
|Mr. Brad Paul Eckenweiler||Founder & Advisor||N/A||N/A||1954|
|Mr. Jan Burian Ph.D.||Chief Technical Officer||N/A||N/A||N/A|
|Dr. Elizabeth Matthews||Head of Scientific & Regulatory Affairs||N/A||N/A||N/A|
Core One Labs Inc. operates as a biotechnology research and technology life sciences company. The company focuses on bringing psychedelic medicines to market through novel delivery systems, psychedelic assisted psychotherapy, and API grade psilocybin manufacturing. Its CannaStrips technology produces infused strips that allow for bioavailability of cannabis constituents. The company also offers consulting, financing, and micro cultivation services, as well as operates medical and wellness clinics. In addition, it provides natural health products; and news dissemination services. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.
Core One Labs Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.